In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Consolidation: Serious Competition for Big Pharma?

Executive Summary

Merck KGAA surprised observers when it announced the €10.6 billion takeover of Europe's biggest biotech, Serono. There was more consolidation to come. That same day, the Danish pharmaceutical group Nycomed Group said it would acquire Altana Pharma for about €4.5 billion in cash. Only a couple days later, UCB SA entered the fray with the acquisition of Schwarz Pharma AG for €4.2 billion in cash and stock. Can these bulked up companies present serious competition for Big Pharma on the licensing front?
Advertisement

Related Content

UCB Bets on Focus, Not Diversification
Schering-Plough Adds to Pipeline with Organon Acquisition
Deal Statistics Quarterly, Q3 2006
Share the Wealth? No Thanks
Auctions: Getting the Best Value for Your Asset
Vertex/J&J: Pushing Big Pharma's Deal Flexibility to the Limit
Schwarz Shops Fesoterodine to Pfizer
Merck KGAA's Hostile Bid Catalyzes Bayer-Schering Combo
Serono Deals Its Way Into Oncology
Bioteching UCB-and Maybe Mid-Sized Pharma, Too

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel